-
1 Comment
Honliv Healthcare Management Group Company Limited is currently in a long term uptrend where the price is trading 12.2% above its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Based on the above factors, Honliv Healthcare Management Group Company Limited gets an overall score of 2/5.
| Industry | Medical Care Facilities |
|---|---|
| Sector | Healthcare |
| ISIN | KYG4594A1040 |
| CurrencyCode | HKD |
| Exchange | HK |
| Dividend Yield | 0.0% |
|---|---|
| Market Cap | 1B |
| Beta | 0.15 |
| Target Price | None |
| PE Ratio | 22.33 |
Honliv Healthcare Management Group Company Limited owns and operates a general hospital in Mainland China. The company provides medical and pharmaceutical services, and hospital management services. It also operates as the pharmaceutical wholesaler. As of December 31, 2021, the company operated and managed Henan Honliv Hospital with 1,500 beds in operation located in Henan Province. The company was founded in 2004 and is headquartered in Changyuan, China. Honliv Healthcare Management Group Company Limited is a subsidiary of Sunny Rock Capital Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 9906.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
